SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED
Clinical trials for SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED explained in plain language.
Never miss a new study
Get alerted when new SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED trials appear
Sign up with your email to follow new studies for SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on viruses in cancer patients
Disease control Recruiting nowThis early-stage trial tests whether specially designed immune cells (T-cells) can safely control viral infections like CMV, BK virus, or COVID-19 in cancer patients with weakened immune systems. The cells are modified to resist common anti-rejection drugs and target specific vir…
Matched conditions: SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Stem cell infusion may tame COVID lung crisis
Disease control Recruiting nowThis study tests whether infusions of stem cells from donated umbilical cord blood can help control severe pneumonia caused by COVID-19 in cancer patients. About 70 adults with moderate to critical illness will receive either stem cells plus standard care or standard care alone. …
Matched conditions: SYMPTOMATIC COVID-19 INFECTION LABORATORY-CONFIRMED
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:57 UTC